ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 38535 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 38535; 2) Community: the network communities that were significantly associated with the response to NSC 38535; 3) Molecule: the relationships between components within communities and NSC 38535; 4) MDR: the compounds that were significantly associated with the NSC 38535.

NSC Compound Enrichment Correlation
NSC 681279 5-Phenyl-4-oxo-oxadiazolo(5,4-c)quinolin-3-N-oxide (furoxan) 0.0114553853234974 0.59083317
NSC 703442 Null 0.0114553853234974 0.59735345
NSC 741898 4-(2-pyridinyl)-5H-1,2,3-dithiazole-5-thione 0.0114553853234974 0.41738427
NSC 135037 Jatrophone 0.0114553853234976 0.79994551
NSC 227279 1,4-Naphthalenedione, 5,8-dihydroxy-2,3-bis(hydroxymethyl)- 0.0114553853234976 0.74685151
NSC 301457 Cycloalkannin 0.0114553853234976 0.81025086
NSC 266047 1,2-Cyclohexanediamine, platinum complex, (1R-trans)- (9CI) 0.0119653763676521 0.4082884
NSC 373355 Saframycin R 0.0119653763676521 0.50178052
NSC 403572 Acetophenone, 4'-bromo-2-hydroxy-, benzoate (8CI) 0.0119653763676522 0.5105944
NSC 610456 Camptothecin Derivative 0.0119653763676522 0.032371764
Total:121  Current:47    [First] [Prev] [Next] [Last]